Ba. Vogt et al., ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODY-POSITIVE CRESCENTIC GLOMERULONEPHRITIS AS A COMPLICATION OF TREATMENT WITH PROPYLTHIOURACIL IN CHILDREN, The Journal of pediatrics, 124(6), 1994, pp. 986-988
Propylthiouracil, which is commonly used in the treatment of hyperthyr
oidism, has been associated in adults with antineutrophil cytoplasmic
autoantibody, a serologic marker of vasculitis. Severe renal disease h
as not been reported as a complication of therapy with this drug. We r
eport severe antineutrophil cytoplasmic autoantibody-positive vasculit
is in children receiving propylthiourocil, as well as rapidly progress
ive crescentic glomerulonephritis after administration of this drug.